| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | glomerulosclerosis | 1.28e-05 | 68 | 30 | 4 | MP:0005264 | |
| MousePheno | increased urine protein level | 1.48e-05 | 149 | 30 | 5 | MP:0002962 | |
| MousePheno | cortical renal glomerulopathies | 1.85e-05 | 156 | 30 | 5 | MP:0000523 | |
| MousePheno | increased B cell number | 2.02e-05 | 271 | 30 | 6 | MP:0005014 | |
| MousePheno | abnormal urine protein level | 2.79e-05 | 170 | 30 | 5 | MP:0006315 | |
| MousePheno | increased pre-B cell number | 3.14e-05 | 29 | 30 | 3 | MP:0003132 | |
| MousePheno | abnormal pre-B cell morphology | 4.99e-05 | 96 | 30 | 4 | MP:0002403 | |
| MousePheno | constricted vagina orifice | 6.64e-05 | 6 | 30 | 2 | MP:0001143 | |
| MousePheno | tremors | 8.83e-05 | 353 | 30 | 6 | MP:0000745 | |
| MousePheno | increased monocyte cell number | 8.94e-05 | 217 | 30 | 5 | MP:0000220 | |
| MousePheno | increased hemoglobin content | 9.43e-05 | 113 | 30 | 4 | MP:0005564 | |
| MousePheno | abnormal B cell number | 9.82e-05 | 526 | 30 | 7 | MP:0002458 | |
| MousePheno | increased hematocrit | 1.31e-04 | 123 | 30 | 4 | MP:0002608 | |
| MousePheno | increased lymphocyte cell number | 2.05e-04 | 797 | 30 | 8 | MP:0005013 | |
| MousePheno | abnormal B cell morphology | 2.16e-04 | 597 | 30 | 7 | MP:0004939 | |
| MousePheno | abnormal renal glomerulus morphology | 2.24e-04 | 264 | 30 | 5 | MP:0005325 | |
| MousePheno | abnormal nephron morphology | 2.47e-04 | 426 | 30 | 6 | MP:0003881 | |
| MousePheno | short tibia | 2.66e-04 | 274 | 30 | 5 | MP:0002764 | |
| MousePheno | albuminuria | 3.25e-04 | 63 | 30 | 3 | MP:0002871 | |
| MousePheno | abnormal renal corpuscle morphology | 3.62e-04 | 293 | 30 | 5 | MP:0002827 | |
| MousePheno | abnormal monocyte cell number | 3.74e-04 | 295 | 30 | 5 | MP:0012441 | |
| MousePheno | abnormal monocyte morphology | 4.10e-04 | 301 | 30 | 5 | MP:0002620 | |
| MousePheno | abnormal lymphocyte cell number | 4.26e-04 | 1390 | 30 | 10 | MP:0000717 | |
| MousePheno | abnormal kidney cortex morphology | 5.74e-04 | 324 | 30 | 5 | MP:0000521 | |
| MousePheno | increased susceptibility to endotoxin shock | 5.86e-04 | 77 | 30 | 3 | MP:0008735 | |
| MousePheno | abnormal pro-B cell morphology | 6.09e-04 | 78 | 30 | 3 | MP:0005432 | |
| MousePheno | renal fibrosis | 6.09e-04 | 78 | 30 | 3 | MP:0003985 | |
| MousePheno | decreased exploration in new environment | 6.44e-04 | 510 | 30 | 6 | MP:0001417 | |
| MousePheno | abnormal lymphocyte morphology | 7.16e-04 | 1483 | 30 | 10 | MP:0002619 | |
| MousePheno | increased IgE level | 7.30e-04 | 83 | 30 | 3 | MP:0002497 | |
| MousePheno | decreased lymphocyte cell number | 8.96e-04 | 992 | 30 | 8 | MP:0005016 | |
| MousePheno | increased neutrophil cell number | 1.02e-03 | 368 | 30 | 5 | MP:0000219 | |
| MousePheno | increased glomerular capsule space | 1.10e-03 | 23 | 30 | 2 | MP:0011501 | |
| MousePheno | abnormal tibia morphology | 1.11e-03 | 375 | 30 | 5 | MP:0000558 | |
| MousePheno | decreased myeloid cell number | 1.12e-03 | 567 | 30 | 6 | MP:0013662 | |
| MousePheno | abnormal cell proliferation | 1.15e-03 | 1294 | 30 | 9 | MP:0000350 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 1.19e-03 | 381 | 30 | 5 | MP:0003857 | |
| MousePheno | premature death | 1.31e-03 | 1051 | 30 | 8 | MP:0002083 | |
| MousePheno | abnormal myeloid cell number | 1.31e-03 | 806 | 30 | 7 | MP:0013661 | |
| MousePheno | decreased B cell number | 1.38e-03 | 394 | 30 | 5 | MP:0005017 | |
| MousePheno | increased cell proliferation | 1.41e-03 | 396 | 30 | 5 | MP:0000351 | |
| MousePheno | increased granulocyte number | 1.46e-03 | 597 | 30 | 6 | MP:0000322 | |
| MousePheno | abnormal liver physiology | 1.49e-03 | 401 | 30 | 5 | MP:0000609 | |
| MousePheno | decreased leukocyte cell number | 1.50e-03 | 1342 | 30 | 9 | MP:0000221 | |
| MousePheno | abnormal glomerular capsule space morphology | 1.51e-03 | 27 | 30 | 2 | MP:0011499 | |
| MousePheno | abnormal renal glomerular capsule morphology | 1.52e-03 | 107 | 30 | 3 | MP:0002828 | |
| MousePheno | increased inflammatory response | 1.53e-03 | 1077 | 30 | 8 | MP:0001846 | |
| MousePheno | abnormal eye physiology | 1.58e-03 | 606 | 30 | 6 | MP:0005253 | |
| MousePheno | abnormal hemoglobin content | 1.61e-03 | 408 | 30 | 5 | MP:0005563 | |
| MousePheno | decreased length of long bones | 1.63e-03 | 409 | 30 | 5 | MP:0004686 | |
| Domain | NPIP | NPIPB8 NPIPB13 NPIPB9 NPIPB6 NPIPA5 NPIPA1 NPIPB3 NPIPA3 NPIPB5 NPIPA7 NPIPA2 NPIPB2 | 6.45e-30 | 14 | 53 | 12 | IPR009443 |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 8.56e-12 | 4 | 61 | 4 | 18055785 | |
| Pubmed | The sequence and analysis of duplication-rich human chromosome 16. | 5.50e-07 | 90 | 61 | 5 | 15616553 | |
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 3.03e-06 | 2 | 61 | 2 | 11586358 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11078732 | ||
| Pubmed | Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT. | 3.03e-06 | 2 | 61 | 2 | 19833725 | |
| Pubmed | Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation. | 9.07e-06 | 3 | 61 | 2 | 30044226 | |
| Pubmed | Erythropoietin protects against diabetes through direct effects on pancreatic beta cells. | 9.07e-06 | 3 | 61 | 2 | 21149549 | |
| Pubmed | Calcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl Isomerization. | 9.07e-06 | 3 | 61 | 2 | 26248042 | |
| Pubmed | Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. | 9.07e-06 | 3 | 61 | 2 | 16116438 | |
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 9.07e-06 | 3 | 61 | 2 | 11948212 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 30314756 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 18846253 | ||
| Pubmed | Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504. | 1.81e-05 | 4 | 61 | 2 | 26941017 | |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 12560487 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 29434323 | ||
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 12009310 | ||
| Pubmed | 2.33e-04 | 13 | 61 | 2 | 12917333 | ||
| Pubmed | 3.57e-04 | 16 | 61 | 2 | 19464057 | ||
| Pubmed | 4.05e-04 | 17 | 61 | 2 | 19716815 | ||
| Pubmed | 5.08e-04 | 19 | 61 | 2 | 17609112 | ||
| Pubmed | 5.63e-04 | 20 | 61 | 2 | 23637629 | ||
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 5.77e-04 | 92 | 61 | 3 | 10493829 | |
| Pubmed | Jak2 is essential for signaling through a variety of cytokine receptors. | 6.22e-04 | 21 | 61 | 2 | 9590173 | |
| Pubmed | 7.48e-04 | 23 | 61 | 2 | 20379146 | ||
| Pubmed | Failure of extra-embryonic progenitor maintenance in the absence of dosage compensation. | 7.48e-04 | 23 | 61 | 2 | 22573614 | |
| Pubmed | A Grhl2-dependent gene network controls trophoblast branching morphogenesis. | 1.03e-03 | 27 | 61 | 2 | 25758223 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.52e-03 | 281 | 61 | 4 | 28706196 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 3.37e-09 | 172 | 61 | 7 | chr16p12 | |
| Cytoband | 16p13.11 | 2.45e-08 | 23 | 61 | 4 | 16p13.11 | |
| Cytoband | 16p12.2 | 1.80e-07 | 37 | 61 | 4 | 16p12.2 | |
| Cytoband | 16p11.2 | 2.20e-07 | 191 | 61 | 6 | 16p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 1.60e-06 | 426 | 61 | 7 | chr16p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 3.54e-05 | 278 | 61 | 5 | chr16p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p24 | 3.96e-03 | 70 | 61 | 2 | chr6p24 | |
| GeneFamily | PHD finger proteins | 7.93e-03 | 90 | 27 | 2 | 88 | |
| GeneFamily | SH2 domain containing | 9.90e-03 | 101 | 27 | 2 | 741 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-06 | 167 | 61 | 5 | 0130743084dbcb20e10f96715d30961122150cbf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-06 | 167 | 61 | 5 | 7bcae3797d3a0811e7f39885afdfd29ec517f11b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-06 | 167 | 61 | 5 | c6f0209a1ad797631fdfa3efab6db6b1d3e8e315 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 3.75e-06 | 171 | 61 | 5 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.94e-06 | 188 | 61 | 5 | de7cb273899d0e0748c85f45c6b5e7f0642ab057 | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.94e-06 | 188 | 61 | 5 | f4734d5b703678670ece204a0519cf015e180a6e | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.10e-06 | 189 | 61 | 5 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | CD8+_Memory_T_cell-CV-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.46e-06 | 197 | 61 | 5 | 9fe3d53346a95c1bbb0fc6a2f2e974889873424b | |
| ToppCell | CV-Moderate-3|CV / Virus stimulation, Condition and Cluster | 7.46e-06 | 197 | 61 | 5 | 7031286e300eaccf73b927939f8de3a9d2d5fc74 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-05 | 119 | 61 | 4 | 8eefcf1ace62ad1c90fa5b62ec159c83ec527bf3 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.54e-05 | 124 | 61 | 4 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.21e-05 | 149 | 61 | 4 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 153 | 61 | 4 | 4b999892fb797e9f0d391630094f466463299d57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 153 | 61 | 4 | e426db29e4ba83e7930dc88c74fc975b177c9540 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 153 | 61 | 4 | 668eacd76aad6054bd7d57e3af0b122c2443465f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.54e-05 | 158 | 61 | 4 | 0c9bb7f8d080a052ca71701544a076c6c2ea67cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.54e-05 | 158 | 61 | 4 | cebb58878b6945074bc1c7d5848d842da5dcbae1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.54e-05 | 158 | 61 | 4 | 2cfa6dd36c8ae534cf1dd49366d4b4433388c1e0 | |
| ToppCell | 15-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 8.68e-05 | 170 | 61 | 4 | 61f8dd5e27df1b8d01ccfd0d25247b34aa8d182c | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-05 | 171 | 61 | 4 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.88e-05 | 171 | 61 | 4 | e6dfbd2652b67577c8834c05348f62150637f348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.88e-05 | 171 | 61 | 4 | ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.08e-05 | 172 | 61 | 4 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.08e-05 | 172 | 61 | 4 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-05 | 176 | 61 | 4 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-05 | 176 | 61 | 4 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-05 | 176 | 61 | 4 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-05 | 176 | 61 | 4 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 177 | 61 | 4 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 178 | 61 | 4 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 178 | 61 | 4 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.08e-04 | 180 | 61 | 4 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-04 | 181 | 61 | 4 | 5cecbafc29cc95896e6ccb2c74d9237b9aaece69 | |
| ToppCell | URO-Myeloid-pDC|URO / Disease, Lineage and Cell Type | 1.18e-04 | 184 | 61 | 4 | 0edb5dd003c2bca0b9e3ec18d03610d68bd52538 | |
| ToppCell | Bac-SEP-Myeloid-pDC|Bac-SEP / Disease, Lineage and Cell Type | 1.20e-04 | 185 | 61 | 4 | 3de50b2042f22b0fb62ff12c76d85cc67649a0bd | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 1.20e-04 | 185 | 61 | 4 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.28e-04 | 188 | 61 | 4 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 189 | 61 | 4 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | Int-URO-Myeloid-pDC|Int-URO / Disease, Lineage and Cell Type | 1.31e-04 | 189 | 61 | 4 | 37aee7a0acd5fd5dd62f22608d72ff8afe210e5c | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.36e-04 | 191 | 61 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 191 | 61 | 4 | 29ce21c6e810edd51f13e0fb1083cd44bd57b1d4 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-04 | 193 | 61 | 4 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.41e-04 | 193 | 61 | 4 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-04 | 194 | 61 | 4 | 4f28841c7f37884fc34c6689cd6976c6559d23f1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid-Microglia|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-04 | 194 | 61 | 4 | 459e836bcdb6742333684ac23d960efa5e99702f | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.44e-04 | 194 | 61 | 4 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 1.44e-04 | 194 | 61 | 4 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 195 | 61 | 4 | 6a0460d949ccda7c9fe76870d3ee6c2f60677d61 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.47e-04 | 195 | 61 | 4 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 195 | 61 | 4 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 196 | 61 | 4 | c7363794fb731848e4343b3a4e4f800f9c81999a | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 199 | 61 | 4 | 5a29db2610ba06a2248325a16cad755d20debf2c | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 199 | 61 | 4 | 0d6463e368fd611a17327322413fad145f3c7f32 | |
| ToppCell | distal-2-Hematologic-CD8+_Naive_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-04 | 199 | 61 | 4 | 454c6dfa621be02a7fefdba431972f68c67f9383 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 199 | 61 | 4 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 199 | 61 | 4 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | dfdfad881c114e1bc9a64b411e1b00fb37cc859b | |
| ToppCell | medial-Hematologic-CD8+_Naive_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 200 | 61 | 4 | 2de8fae1011c57270170fb200a8897add7fe9bfc | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | cded40d5069a6fdbd90ac9a2a0bbef11727b28d5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-04 | 200 | 61 | 4 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | 20ffb3436d08042f77800513e6ddb3bbc38ae6fe | |
| ToppCell | distal-Hematologic-CD8+_Naive_T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 200 | 61 | 4 | 78c70174911ee465da6b0d1f4aee27043be492cd | |
| ToppCell | medial-2-Hematologic-CD8+_Naive_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 200 | 61 | 4 | 5e5c1c5b6d2fcfad7b93488b976a68f5be1435e5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | medial-Hematologic-CD8+_Naive_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 200 | 61 | 4 | 2daa445f983a43ff3ace1198a6793f5c6706bdba | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.62e-04 | 200 | 61 | 4 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | 66fb892bda1d29e67a65717e85f2ec221f520b2a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-04 | 200 | 61 | 4 | 26251ed8c7fa7e87973d6f59bd398c88ad025395 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | distal-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 200 | 61 | 4 | 2785225956d2422acab90e99b7debe3709cf3308 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | 9ef322486e46e4ff05a8cbe06cf8019e996c94b3 | |
| Disease | lysophosphatidylcholine 20:3 measurement | 4.33e-05 | 40 | 50 | 3 | EFO_0010362 | |
| Disease | selective IgA deficiency disease | 6.60e-05 | 46 | 50 | 3 | EFO_1001929 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 8.48e-05 | 50 | 50 | 3 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 9.00e-05 | 51 | 50 | 3 | EFO_0022331 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.32e-04 | 58 | 50 | 3 | EFO_0022338 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.33e-04 | 291 | 50 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | phosphatidylcholine 40:7 measurement | 2.17e-04 | 13 | 50 | 2 | EFO_0021477 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.53e-04 | 181 | 50 | 4 | DOID:684 (is_implicated_in) | |
| Disease | multiple sclerosis | 4.86e-04 | 594 | 50 | 6 | MONDO_0005301 | |
| Disease | apolipoprotein A 1 measurement | 5.38e-04 | 848 | 50 | 7 | EFO_0004614 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 5.51e-04 | 94 | 50 | 3 | EFO_0008595, EFO_0010351 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 6.40e-04 | 99 | 50 | 3 | EFO_0004574, EFO_0008595 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 7.39e-04 | 104 | 50 | 3 | EFO_0008591, EFO_0008595 | |
| Disease | body fat percentage, coronary artery disease | 7.58e-04 | 24 | 50 | 2 | EFO_0001645, EFO_0007800 | |
| Disease | Alzheimer disease, educational attainment | 8.16e-04 | 247 | 50 | 4 | EFO_0011015, MONDO_0004975 | |
| Disease | diastolic blood pressure, alcohol drinking | 1.07e-03 | 118 | 50 | 3 | EFO_0004329, EFO_0006336 | |
| Disease | Global developmental delay | 1.50e-03 | 133 | 50 | 3 | C0557874 | |
| Disease | alkaline phosphatase measurement | 1.53e-03 | 1015 | 50 | 7 | EFO_0004533 | |
| Disease | mean arterial pressure | 1.54e-03 | 499 | 50 | 5 | EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLQPSLDIKPFLPFP | 26 | Q9H6B1 | |
| LFVPPVAPRPPALKL | 376 | P78314 | |
| KPTRRKPPCSLPLFP | 41 | Q6JBY9 | |
| KPPCSLPLFPPKVDL | 46 | Q6JBY9 | |
| FLLPPPCKKCLSPPT | 11 | Q9H7B7 | |
| NLKTPPECVLTPLPP | 281 | Q92617 | |
| LKTPPECVLTPLPPS | 301 | Q92617 | |
| KTPPECLLTPLPPSA | 321 | Q92617 | |
| LLPPQPVKQFLISPP | 136 | Q9UKA8 | |
| LAKLRPPTPPVPDIC | 346 | Q6ZMN7 | |
| CPLDTLRVPPPLTPL | 251 | P11161 | |
| KDPSLLNFPPPLPAL | 236 | Q14739 | |
| KTPPECLLTPLPPSA | 306 | Q9UND3 | |
| NLKTPPECVLTPLPP | 281 | F8W0I5 | |
| LKTPPECLLTPLPPS | 301 | F8W0I5 | |
| KTPPECLLTPLPPSA | 321 | F8W0I5 | |
| KPPSPVCLDLFPVAP | 41 | Q8IW93 | |
| PKPLVPAIPICSIPV | 376 | Q13469 | |
| PCIRKFPTPPASQPL | 66 | C9J6K1 | |
| ERYPLPTVLPPLCPK | 146 | A6NJV1 | |
| CQLLPLFLPPTTVPP | 241 | Q9UBB6 | |
| PPPRCSLLELPPELL | 61 | Q5XUX0 | |
| LKTPPECLLTPLPPS | 281 | E9PQR5 | |
| LKECLFVPLPPSPLP | 321 | E9PQR5 | |
| NLKECLFVPLPPSPL | 341 | E9PQR5 | |
| LLKPLFPTCPVPEEA | 156 | Q01650 | |
| LFLPPQLKPARIPDP | 156 | Q8TD35 | |
| PTCVLPDSVVKPLPP | 526 | P48357 | |
| NLKTPPECVLTPLPP | 281 | A8MRT5 | |
| LKTPPECVLTPLPPS | 301 | A8MRT5 | |
| KTPPECLLTPLPPSA | 321 | A8MRT5 | |
| LLKPLFPTCPVPEEA | 156 | Q9GIP4 | |
| TPPKDKCLSPDLPLP | 151 | Q9BZE0 | |
| NIKECPLAPLPPSPL | 281 | O75200 | |
| KTPPECLLTPLPPSA | 306 | F8WFD2 | |
| KGLLCDIPPPFPNLL | 316 | Q9P242 | |
| SLKTPPECLLTPLPP | 281 | E9PIF3 | |
| NLKTPPECVLTPLPP | 281 | C9JG80 | |
| LKTPPECVLTPLPPS | 301 | C9JG80 | |
| KTPPECLLTPLPPSA | 321 | C9JG80 | |
| CKKLSPPPLPPRASI | 151 | O00750 | |
| PDPGAPVKLPCLPVK | 221 | Q9C0D0 | |
| PVKLPCLPVKLSPPL | 226 | Q9C0D0 | |
| KCLLLPPSFPPPHRQ | 321 | Q6MZQ0 | |
| NLKTPPECLLTPLPP | 281 | E5RHQ5 | |
| LKTPPECLLTPLPPS | 301 | E5RHQ5 | |
| KTKPLPPDPPRLECV | 946 | Q9Y2H6 | |
| LPLEPPAAKTGCPPL | 341 | Q9NP62 | |
| LCPELPPTPPHLKYL | 441 | P19235 | |
| PKADSLCPRLPVPPS | 156 | Q8N4M1 | |
| LCPRLPVPPSKSFPL | 161 | Q8N4M1 | |
| QLRLKPPPPVAILPL | 366 | Q13574 | |
| PLFLAEPALPKGLPP | 1001 | Q13255 | |
| VPRSYELLKPPPICP | 421 | Q9UKT9 | |
| NNFPPLPKFIPLKPC | 6 | Q8TAC9 | |
| LPTAPPELCLLLPPD | 201 | P0C264 | |
| LKECLFVPLPPSPLP | 321 | E9PJ23 | |
| NIKECPLAPLPPSPL | 296 | F8W1W9 | |
| NLKTPPECVLTPLPP | 281 | A6NJU9 | |
| LKTPPECLLTPLPPS | 301 | A6NJU9 | |
| KTPPECLLTPLPPSA | 321 | A6NJU9 | |
| NLKTPPECLLTPLPP | 281 | E9PJI5 | |
| NLKTPPECLLTPLPP | 281 | P0DM63 | |
| RPKFSLPPPLQLIPE | 436 | P07332 | |
| APPLVLPPKELALPL | 651 | Q5VWG9 | |
| PLKAPRENPCFPLPA | 56 | O75920 | |
| IDPPLAPLPRPCMSI | 11 | A0AVI2 | |
| NLKTPPECLLTPLPP | 281 | E9PKD4 | |
| GCISPSLPPPPLKLL | 536 | Q92766 | |
| KCPTEVLLTPPTPLP | 61 | Q6ZMT1 | |
| PPAKLPCLSPEALLV | 276 | A8MX80 | |
| NLKTPPECLLTPLPP | 296 | A6NJ64 | |
| PPAKLPCLSPEALLV | 246 | A8MV72 | |
| PPAKLPCLSPEALLV | 276 | Q8N9G6 | |
| PPAKFPCLSPEALLV | 276 | A8MUI8 | |
| PPAKLPCLSPEALLV | 276 | A8MUA0 | |
| PAPTPPLLVALLCLF | 211 | Q13470 | |
| PPRLPLAVSLKPPFL | 256 | Q9ULC8 | |
| APSSLPPLPPKVLVC | 261 | Q86YW5 | |
| PFLIPSPPICQTEPL | 16 | Q6N021 | |
| PALAPEPPLIPKLLV | 596 | Q562E7 | |
| PLPIFQEVPFAPPLC | 146 | Q6PEX7 | |
| IFCLLPPLPEIPKGV | 351 | P41229 |